XERO LIMITED (XRO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRO - XERO LIMITED

FNArena Sector : Accountancy
Year End: March
GICS Industry Group : Software & Services
Debt/EBITDA: 3.85
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Xero Ltd is a New Zealand software company providing cloud-based accounting software platforms to small and medium sized businesses. Xero has over two million subscribers. Founded in 2006 the company listed in 2012 and has since expanded into Australia, the UK and the US.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$121.96

12 Apr
2024

0.160

OPEN

$122.10

0.13%

HIGH

$122.66

976,192

LOW

$121.20

TARGET
$126.483 3.7% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
RKN .
FNARENA'S MARKET CONSENSUS FORECASTS
XRO: 1
Title FY24
Forecast
FY25
Forecast
EPS (cps) 68.8 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 177.2 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-69.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx1,275.5 M
Book Value Per Share xxxxxxxxxxxxxxx651.8
Net Operating Cash Flow xxxxxxxxxxxxxxx355.8 M
Net Profit Margin xxxxxxxxxxxxxxx-8.11 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-10.65 %
Return on Invested Capital xxxxxxxxxxxxxxx-5.27 %
Return on Assets xxxxxxxxxxxxxxx-4.60 %
Return on Equity xxxxxxxxxxxxxxx-10.65 %
Return on Total Capital xxxxxxxxxxxxxxx3.93 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx349.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx16 M
Long Term Debt xxxxxxxxxxxxxxx1,052 M
Total Debt xxxxxxxxxxxxxxx1,068 M
Goodwill - Gross xxxxxxxxxxxxxxx309 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,044 M
Price To Book Value xxxxxxxxxxxxxxx13.72

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx260.4 M
Capex % of Sales xxxxxxxxxxxxxxx20.42 %
Cost of Goods Sold xxxxxxxxxxxxxxx353 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx845 M
Research & Development xxxxxxxxxxxxxxx290 M
Investments - Total xxxxxxxxxxxxxxx30 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxx xx xxxxxxxxxx xxxx xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

01/03/2024

1

Buy

$139.30

14.22%

Buy rating retained with an $139 price target as UBS analysts continue to feel comfortable with their projections and assumptions, post Xero's first ever Investor Day.

The company has expressed the ambition to double its revenues, without attaching an explicit time frame to the target.

Overall, the broker highlights, A&NZ and the UK will remain the core growth drivers over the next five years. It also seems conditions in the USA are improving, UBS reports.

FORECAST
UBS forecasts a full year FY24 dividend of 0.00 cents and EPS of 1.03 cents.
UBS forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.41 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

XRO STOCK CHART